A M Kremer1, T M Pal, A R J van Keimpema. 1. TNO Work and Employment, P.O. Box 718, 2130 AS, Hoofddorp, The Netherlands. a.kremer@arbeid.tno.nl
Abstract
OBJECTIVES: The aim was to gain insight into work experiences and problems of subjects with chronic obstructive pulmonary disease (COPD) to develop more effective guidelines for preventing work disability and work loss. METHODS: A total of 617 patients aged 45-60, recruited from pulmonary outpatient clinics and general practices, completed a questionnaire on (respiratory) health and work history. RESULTS: Of the patients 43% were female, 52% were employed and more than half were less educated. Comorbidity was present in 52% of the study group. Of those who stopped working (N=260), 36% stopped before the onset of COPD, 39% stopped because of COPD and 25%, although having COPD, had other reasons to stop. Of the patients with a work history 39% had an invalidity benefit: 21% of the working and 60% of the non-working patients. For one-third of these patients COPD was not the reason for having an invalidity benefit. For 56% of those who had a benefit because of COPD, comorbidity contributed to work disability. No difference in current smoking habit was seen between working patients and non-working patients. Yet, non-working patients were more often smokers at the moment they stopped working. Furthermore, former smokers who still worked stopped smoking at a younger age than former smokers who stopped working. Compared with workers and independent of smoking habit, former workers were more exposed to dust/irritants, had their work(place) less frequently modified and had more unfavourable (social) work experiences. CONCLUSION: For employees with COPD, work loss is often multi-factorial. Comorbidity is often present and an important cause for work loss. Therefore occupational health guidance has to take other interfering (health) factors than COPD into consideration as well. In preventing work disability, work(place) adjustment merits more attention.
OBJECTIVES: The aim was to gain insight into work experiences and problems of subjects with chronic obstructive pulmonary disease (COPD) to develop more effective guidelines for preventing work disability and work loss. METHODS: A total of 617 patients aged 45-60, recruited from pulmonary outpatient clinics and general practices, completed a questionnaire on (respiratory) health and work history. RESULTS: Of the patients 43% were female, 52% were employed and more than half were less educated. Comorbidity was present in 52% of the study group. Of those who stopped working (N=260), 36% stopped before the onset of COPD, 39% stopped because of COPD and 25%, although having COPD, had other reasons to stop. Of the patients with a work history 39% had an invalidity benefit: 21% of the working and 60% of the non-working patients. For one-third of these patientsCOPD was not the reason for having an invalidity benefit. For 56% of those who had a benefit because of COPD, comorbidity contributed to work disability. No difference in current smoking habit was seen between working patients and non-working patients. Yet, non-working patients were more often smokers at the moment they stopped working. Furthermore, former smokers who still worked stopped smoking at a younger age than former smokers who stopped working. Compared with workers and independent of smoking habit, former workers were more exposed to dust/irritants, had their work(place) less frequently modified and had more unfavourable (social) work experiences. CONCLUSION: For employees with COPD, work loss is often multi-factorial. Comorbidity is often present and an important cause for work loss. Therefore occupational health guidance has to take other interfering (health) factors than COPD into consideration as well. In preventing work disability, work(place) adjustment merits more attention.
Authors: John Balmes; Margaret Becklake; Paul Blanc; Paul Henneberger; Kathleen Kreiss; Cristina Mapp; Donald Milton; David Schwartz; Kjell Toren; Giovanni Viegi Journal: Am J Respir Crit Care Med Date: 2003-03-01 Impact factor: 21.405
Authors: L Trupin; G Earnest; M San Pedro; J R Balmes; M D Eisner; E Yelin; P P Katz; P D Blanc Journal: Eur Respir J Date: 2003-09 Impact factor: 16.671
Authors: J G van Manen; P J Bindels; C J IJzermans; J S van der Zee; B J Bottema; E Schadé Journal: J Clin Epidemiol Date: 2001-03 Impact factor: 6.437
Authors: Karin H Orbon; Tjard R Schermer; Joost W van der Gulden; Niels H Chavannes; Reinier P Akkermans; Onno P van Schayck; Chris van Weel; Hans T Folgering Journal: Int Arch Occup Environ Health Date: 2005-05-13 Impact factor: 3.015
Authors: F Andries; C W Wevers; A R Wintzen; H F Busch; C J Höweler; A E de Jager; G W Padberg; M de Visser; J H Wokke Journal: Int J Rehabil Res Date: 1997-09 Impact factor: 1.479
Authors: Peter A Jacobsen; Alex J van 't Hul; Remco S Djamin; Jeanine C Antons; Marianne de Man; Ulla Møller Weinreich; Martijn A Spruit; Daisy J A Janssen Journal: Respir Res Date: 2021-05-12
Authors: Monica J Fletcher; Jane Upton; Judith Taylor-Fishwick; Sonia A Buist; Christine Jenkins; John Hutton; Neil Barnes; Thys Van Der Molen; John W Walsh; Paul Jones; Samantha Walker Journal: BMC Public Health Date: 2011-08-01 Impact factor: 3.295
Authors: Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-04-03 Impact factor: 8.082
Authors: Kiran K Rai; Rachel E Jordan; W Stanley Siebert; Steven S Sadhra; David A Fitzmaurice; Alice J Sitch; Jon G Ayres; Peymané Adab Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-01-11
Authors: Eva Esteban; Michaela Coenen; Elizabeth Ito; Sonja Gruber; Chiara Scaratti; Matilde Leonardi; Olga Roka; Evdokia Vasilou; Amalia Muñoz-Murillo; Carolina C Ávila; Dare S Kovačič; Ivana Ivandic; Carla Sabariego Journal: Int J Environ Res Public Health Date: 2018-05-18 Impact factor: 3.390